Syndax Pharmaceuticals Overview
Syndax Pharmaceuticals Target Price
Where could SNDX trade next? Consensus target price: $38.
Get informed when a big investor buys or sells
+ FollowShare Price
$20.1
Average Target Price
$37.50
86.6% upside
86.6% upside6 analysts in the last 4 months
High: $46 | Low: $31
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-21 | UBSDavid Dai | $33 | 64.2% upside |  |
| 2026-08-05 | H.C. Wainwright | $38 | 89.1% upside | |
| 2026-06-12 | GuggenheimBrad Canino | $31 | 54.2% upside | |
| 2026-06-03 | H.C. WainwrightAndres Maldonado | $40 | 99% upside | |
| 2026-05-04 | Stifel Nicolaus | $46 | 128.9% upside | |
| 2026-05-01 | Barclays | $37 | 84.1% upside | |
| 2026-02-27 | Stifel NicolausStephen Willey | $45 | 123.9% upside | |
| 2025-11-24 | Barclays | $35 | 74.1% upside | |
| 2025-11-04 | UBS | $38 | 89.1% upside | |
| 2025-11-04 | BarclaysPeter Lawson | $22 | 9.5% upside | |
| 2025-09-10 | Stifel Nicolaus | $44 | 118.9% upside | |
| 2025-07-15 | UBSDavid Dai | $35 | 74.1% upside | |
| 2025-07-10 | Goldman SachsCorinne Johnson | $18 |  10.4% downside | |
| 2024-11-13 | ScotiabankGeorge Farmer | $18 | 10.4% downside | |
| 2024-10-24 | UBSDavid Dai | $37 | 84.1% upside | |
| 2024-08-15 | CitigroupYigal Nochomovitz | $34 | 69.2% upside | |
| 2024-08-15 | Bank of America SecuritiesJason Zemansky | $31 | 54.2% upside | |
| 2024-08-15 | BarclaysPeter Lawson | $33 | 64.2% upside | |
| 2024-07-30 | Bank of America SecuritiesJason Zemansky | $30 | 49.3% upside | |
| 2024-06-28 | JefferiesKelly Shi | $37 | 84.1% upside | |
| 2024-05-09 | Stifel NicolausBradley Canino | $40 | 99% upside | |
| 2023-01-03 | J.P. Morgan | $41 | 104% upside | |
| 2022-12-12 | Goldman Sachs | $39 | 94% upside | |
| 2022-12-12 | H.C. Wainwright | $33 | 64.2% upside | |